Text Size
3 studies found for:    16684987 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade(Registered Trademark)), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroi...
Conditions: Breast Cancer;   Colon Cancer;   Prostate Cancer;   Lung Cancer;   Adrenal Cancer;   Renal Cancer;   Gastric Cancer;   Ovarian Cancer;   Cervical Cancer;   Thyroid Cancer;   Sarcoma
Interventions: Drug: VELCADE, PS-341 (Bortezomib, NSC #681239);   Drug: ZACTIMA (Vandetanib) (ZD6474)
2 Recruiting A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
Condition: Thyroid Neoplasm
Intervention: Drug: Valproic Acid
3 Recruiting A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
Conditions: Solid Tumor;   Anaplastic Thyroid Cancer
Interventions: Drug: Cisplatin and Crolibulin;   Drug: Cisplatin
To Top

† Indicates status has not been verified in more than two years